GuideAI Health (NEOE:GDAI) Beta: N/A (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NEOE:GDAI GuideAI Health Corp NEOE:GDAI
11 GF Score
Price C$1.00
View Full Analysis

What is GuideAI Health Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-27), GuideAI Health's Beta is Not available.

GuideAI Health  (NEOE:GDAI) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

GuideAI Health Beta Related Terms

GuideAI Health Beta Historical Data

* Premium members only.

The historical data trend for GuideAI Health's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GuideAI Health Beta Chart

GuideAI Health Annual Data
Trend Jun23 Jun24 Jun25
Beta
0.00 0.00 0.00

GuideAI Health Quarterly Data
Jun23 Jun24 Mar25 Jun25 Mar26
Beta 0.00 0.00 0.00 0.00 0.00
NEOE:GDAI
11GF Score
GuideAI Health Corp NEOE:GDAI
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GuideAI Health Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

GuideAI Health Business Description

Address 550 Burrard Street, Suite 2300, Vancouver, BC, CAN, V6C 2B5
GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others.
11GF Score

Get the complete analysis for NEOE:GDAI

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.00
Price